DK358875A - - Google Patents

Info

Publication number
DK358875A
DK358875A DK358875A DK358875A DK358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A
Authority
DK
Denmark
Application number
DK358875A
Other languages
Danish (da)
Other versions
DK139101C (cg-RX-API-DMAC7.html
DK139101B (da
Inventor
C Casagrande
G Ferrari
Original Assignee
Siphar S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar S A filed Critical Siphar S A
Publication of DK358875A publication Critical patent/DK358875A/da
Publication of DK139101B publication Critical patent/DK139101B/da
Application granted granted Critical
Publication of DK139101C publication Critical patent/DK139101C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK358875AA 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. DK139101B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1085574A CH621803A5 (cg-RX-API-DMAC7.html) 1974-08-08 1974-08-08

Publications (3)

Publication Number Publication Date
DK358875A true DK358875A (cg-RX-API-DMAC7.html) 1976-02-09
DK139101B DK139101B (da) 1978-12-18
DK139101C DK139101C (cg-RX-API-DMAC7.html) 1979-05-21

Family

ID=4367535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358875AA DK139101B (da) 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser.

Country Status (12)

Country Link
US (1) US4000125A (cg-RX-API-DMAC7.html)
JP (1) JPS5141372A (cg-RX-API-DMAC7.html)
AR (1) AR217617A1 (cg-RX-API-DMAC7.html)
BE (1) BE832271A (cg-RX-API-DMAC7.html)
CA (1) CA1049499A (cg-RX-API-DMAC7.html)
CH (1) CH621803A5 (cg-RX-API-DMAC7.html)
DE (1) DE2534981A1 (cg-RX-API-DMAC7.html)
DK (1) DK139101B (cg-RX-API-DMAC7.html)
ES (1) ES440110A1 (cg-RX-API-DMAC7.html)
FR (1) FR2281124A1 (cg-RX-API-DMAC7.html)
GB (1) GB1484655A (cg-RX-API-DMAC7.html)
SE (1) SE418401B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144136B (it) * 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
US5373095A (en) * 1985-10-18 1994-12-13 The Upjohn Company Steroid compounds
IT1262931B (it) * 1992-01-16 1996-07-22 Zambon Spa Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
PT2206719E (pt) * 2005-03-02 2015-02-05 Univ Maryland Composição farmacêutica compreendendo 3-beta-hidroxi-17- (1-h-benzimidazol-1-il)androsta-5,16-dieno
US20110105445A1 (en) * 2008-03-12 2011-05-05 University Of Maryland, Baltimore Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer
US20100048914A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
US20110118219A1 (en) * 2008-03-25 2011-05-19 University Of Maryland, Baltimore Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
US8785423B2 (en) * 2008-04-14 2014-07-22 University Of Maryland, Baltimore Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases
BRPI1008745A2 (pt) 2009-02-05 2019-09-17 Tokai Pharmaceuticals Inc pró-fármacos de inibidores esteroidais de cyp17/antiandrogênios
US8791095B2 (en) 2009-02-05 2014-07-29 Tokai Pharmaceuticals, Inc. Steroidal CYP17 inhibitors/antiandrogens
BR112012002797A2 (pt) 2009-08-07 2019-09-24 Tokai Pharmaceuticals Inc tratamento de câncer de próstata
CN105682662A (zh) 2013-03-14 2016-06-15 马里兰大学巴尔的摩校区 雄激素受体减量调节剂及其用途
BR112016002970A2 (pt) 2013-08-12 2017-09-12 Tokai Pharmaceuticals Inc biomarcadores para o tratamento de distúrbios neoplásicos que usa terapias direcionadas ao androgênio
WO2017001204A1 (en) * 2015-06-29 2017-01-05 Universiteit Gent Methods for the site-selective coupling of a first agent to a second agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838163A (en) * 1968-11-22 1974-09-24 Hoffmann La Roche Substituted isoxazole derivatives as steroid intermediates

Also Published As

Publication number Publication date
BE832271A (fr) 1975-12-01
CH621803A5 (cg-RX-API-DMAC7.html) 1981-02-27
US4000125A (en) 1976-12-28
DK139101C (cg-RX-API-DMAC7.html) 1979-05-21
AR217617A1 (es) 1980-04-15
SE418401B (sv) 1981-05-25
CA1049499A (en) 1979-02-27
DE2534981A1 (de) 1976-02-19
DK139101B (da) 1978-12-18
SE7508908L (sv) 1976-02-09
JPS5141372A (cg-RX-API-DMAC7.html) 1976-04-07
ES440110A1 (es) 1977-02-16
FR2281124B1 (cg-RX-API-DMAC7.html) 1980-05-16
GB1484655A (en) 1977-09-01
FR2281124A1 (fr) 1976-03-05

Similar Documents

Publication Publication Date Title
FR2281124B1 (cg-RX-API-DMAC7.html)
DK138743C (cg-RX-API-DMAC7.html)
FR2258901A1 (cg-RX-API-DMAC7.html)
DK136820C (cg-RX-API-DMAC7.html)
FI753017A7 (cg-RX-API-DMAC7.html)
AU495883B2 (cg-RX-API-DMAC7.html)
FI49388B (cg-RX-API-DMAC7.html)
AU7459574A (cg-RX-API-DMAC7.html)
AU495844B2 (cg-RX-API-DMAC7.html)
AU485022B2 (cg-RX-API-DMAC7.html)
AU7099174A (cg-RX-API-DMAC7.html)
AU7253574A (cg-RX-API-DMAC7.html)
BG19946A1 (cg-RX-API-DMAC7.html)
BG19727A1 (cg-RX-API-DMAC7.html)
CH588331A5 (cg-RX-API-DMAC7.html)
CH581413A5 (cg-RX-API-DMAC7.html)
CH576764A5 (cg-RX-API-DMAC7.html)
CH575876A5 (cg-RX-API-DMAC7.html)
BG19999A1 (cg-RX-API-DMAC7.html)
BG19987A1 (cg-RX-API-DMAC7.html)
BG19967A1 (cg-RX-API-DMAC7.html)
BG19620A1 (cg-RX-API-DMAC7.html)
BG19917A1 (cg-RX-API-DMAC7.html)
BG19908A1 (cg-RX-API-DMAC7.html)
BG19866A1 (cg-RX-API-DMAC7.html)